Patent details

Basic Information

Publication number:

EP2011862

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP080180573

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

German

English Title of Invention:

Method for manufacturing an active component of a medicine or diagnosis agent in MDCK cell suspension culture

French Title of Invention:

Procédé de fabrication d'un composant actif pour médicament ou agent de diagnostic dans une culture en suspension de cellules MDCK

German Title of Invention:

Verfahren zur Herstellung eines aktiven Bestandteils eines Arznei- oder Diagnosemittels im MDCK-Zell-Suspensionskultur

SPC Number:

Dates

Filing date:

11/09/2002

Grant date:

08/06/2011

EP Publication Date:

08/06/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/01/2009

EP B1 Publication Date:

08/06/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/09/2013

Expiration date:

11/09/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/09/2002

 

 

Name:

Novartis Vaccines and Diagnostics GmbH

Address:

Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/08/2011

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Gregersen Jens-Peter

Address:

Germany (DE)

2

Name:

Frech Christian

Address:

Germany (DE)

3

Name:

Vorlop Jürgen

Address:

Germany (DE)

4

Name:

Lübben Holger

Address:

Germany (DE)

Priority

Priority Number:

10144906

Priority Date:

12/09/2001

Priority Country:

Germany (DE)

Classification

Main IPC Class:

C12N 5/07;

Filing date	Document type	Number of pages